Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Thymoma × saracatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Colonic Neoplasms 1

Interventions

N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Celecoxib 2 selinexor 1 saracatinib 1 TP protocol 1 FANG vaccine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00718809 2015-06-10

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

National Cancer Institute (NCI)

Phase 2 Terminated

21 enrolled 13 charts

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡